| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 ATP8A1 CENPE SMCHD1 SMARCAL1 PSMC1 ABCC2 MORC2 SMC2 DNAH5 ABCB4 | 4.11e-05 | 614 | 82 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8A1 GBP7 EIF2S3 SMCHD1 PSMC1 EIF2S3B ABCC2 MORC2 SMC2 DNAH5 ABCB4 | 3.18e-04 | 775 | 82 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.54e-04 | 441 | 82 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8A1 GBP7 EIF2S3 SMCHD1 PSMC1 EIF2S3B ABCC2 MORC2 SMC2 DNAH5 ABCB4 | 6.20e-04 | 839 | 82 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8A1 GBP7 EIF2S3 SMCHD1 PSMC1 EIF2S3B ABCC2 MORC2 SMC2 DNAH5 ABCB4 | 6.26e-04 | 840 | 82 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8A1 GBP7 EIF2S3 SMCHD1 PSMC1 EIF2S3B ABCC2 MORC2 SMC2 DNAH5 ABCB4 | 6.26e-04 | 840 | 82 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 8.36e-04 | 45 | 82 | 3 | GO:0043495 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 2.31e-04 | 6 | 83 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 2.31e-04 | 6 | 83 | 2 | GO:0097728 | |
| Domain | SMC_hinge | 2.76e-04 | 6 | 81 | 2 | PF06470 | |
| Domain | SMC_hinge | 2.76e-04 | 6 | 81 | 2 | SM00968 | |
| Domain | SMC_hinge | 2.76e-04 | 6 | 81 | 2 | IPR010935 | |
| Domain | P-loop_NTPase | MYH9 GBP7 CENPE EIF2S3 SMARCAL1 APAF1 PSMC1 ABCC2 SMC2 DNAH5 ABCB4 | 1.05e-03 | 848 | 81 | 11 | IPR027417 |
| Domain | Znf_C2H2_matrin | 1.19e-03 | 12 | 81 | 2 | IPR000690 | |
| Domain | ZF_MATRIN | 2.72e-03 | 18 | 81 | 2 | PS50171 | |
| Domain | - | 3.36e-03 | 20 | 81 | 2 | 3.30.565.10 | |
| Domain | AAA+_ATPase | 3.56e-03 | 144 | 81 | 4 | IPR003593 | |
| Domain | AAA | 3.56e-03 | 144 | 81 | 4 | SM00382 | |
| Domain | HATPase_C | 3.70e-03 | 21 | 81 | 2 | IPR003594 | |
| Domain | Znf_C2H2_jaz | 4.06e-03 | 22 | 81 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 4.06e-03 | 22 | 81 | 2 | PF12171 | |
| Domain | PWWP | 4.82e-03 | 24 | 81 | 2 | PS50812 | |
| Domain | ABC_membrane | 4.82e-03 | 24 | 81 | 2 | PF00664 | |
| Domain | - | 4.94e-03 | 746 | 81 | 9 | 3.40.50.300 | |
| Domain | Transl_B-barrel | 6.08e-03 | 27 | 81 | 2 | IPR009000 | |
| Domain | ABC_TM1F | 6.53e-03 | 28 | 81 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 6.53e-03 | 28 | 81 | 2 | IPR011527 | |
| Domain | ZnF_U1 | 6.99e-03 | 29 | 81 | 2 | SM00451 | |
| Domain | Znf_U1 | 6.99e-03 | 29 | 81 | 2 | IPR003604 | |
| Domain | IQ_motif_EF-hand-BS | 7.04e-03 | 90 | 81 | 3 | IPR000048 | |
| Domain | IQ | 7.71e-03 | 93 | 81 | 3 | PS50096 | |
| Domain | - | 8.65e-03 | 97 | 81 | 3 | 3.10.100.10 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.61e-06 | 99 | 52 | 6 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.74e-05 | 103 | 52 | 5 | M758 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 5.16e-05 | 20 | 52 | 3 | MM1496 | |
| Pubmed | MYH9 ERLIN2 PDE6A SLC22A14 SYNE1 SMCHD1 UGGT1 KTN1 NFXL1 MAP7D2 MPHOSPH10 ZFC3H1 ABCC2 SMC2 PNISR CEP128 CAMSAP2 HDGFL2 HNRNPC ABCB4 ZNF292 | 2.18e-11 | 1442 | 84 | 21 | 35575683 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL10A NCOR2 MYH9 VRK3 CELF1 BAZ2B SMCHD1 ZNF644 KTN1 ANKRD11 ZNF638 NFXL1 ZFC3H1 SMC2 PNISR HDGFL2 ESCO1 HNRNPC NOL8 | 2.02e-10 | 1294 | 84 | 19 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPL10A NCOR2 BAZ2B UTP11 EIF2S3 SMCHD1 ZNF644 KTN1 ANKRD11 ZNF638 SGO2 EIF2S3B MPHOSPH10 HDGFL2 HNRNPC NOL8 | 1.01e-09 | 954 | 84 | 16 | 36373674 |
| Pubmed | RPL10A ANK3 UBR5 EIF2S3 SYNE1 ZNF644 UGGT1 KTN1 APAF1 ANKRD11 NFXL1 MAP7D2 NUMB ZFC3H1 CACYBP TIMM44 HDGFL2 ARMC1 NOL8 | 2.03e-09 | 1487 | 84 | 19 | 33957083 | |
| Pubmed | NCOR2 MYH9 UBR5 EIF2S3 SYNE1 SMCHD1 ZNF638 PSMC1 EIF2S3B MPHOSPH10 CACYBP MORC2 FSCB | 3.21e-08 | 754 | 84 | 13 | 35906200 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL10A AARS1 MYH9 UBR5 EIF2S3 SMCHD1 UGGT1 KTN1 ZNF638 PSMC1 EIF2S3B CACYBP CPS1 SMC2 TIMM44 HDGFL2 HNRNPC | 4.03e-08 | 1415 | 84 | 17 | 28515276 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | RPL10A NCOR2 AARS1 RESF1 VRK3 ORC6 GON4L TIMM44 ZNF518A ZNF292 | 4.48e-08 | 398 | 84 | 10 | 35016035 |
| Pubmed | NCOR2 AARS1 RESF1 CELF1 UBR5 BAZ2B ORC6 EIF2S3 SMCHD1 ZNF644 PSMC1 CACYBP MORC2 SMC2 ZNF292 | 5.75e-08 | 1103 | 84 | 15 | 34189442 | |
| Pubmed | RPL10A NCOR2 MYH9 UBR5 EIF2S3 KTN1 PSMC1 EIF2S3B SMC2 HDGFL2 HNRNPC | 7.36e-08 | 538 | 84 | 11 | 28524877 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL10A AARS1 MYH9 ERLIN2 EIF2S3 SYNE1 SMCHD1 UGGT1 KTN1 PSMC1 SGO2 CACYBP SMC2 TIMM44 DNAH5 HNRNPC | 2.67e-07 | 1425 | 84 | 16 | 30948266 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL10A CENPE EIF2S3 SMCHD1 KTN1 SGO2 ATG14 MPHOSPH10 ZFC3H1 SMC2 MTCH1 NOL8 | 2.88e-07 | 759 | 84 | 12 | 35915203 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | AARS1 ERLIN2 ANK3 RASGRF2 CENPE KTN1 ANKRD11 MORC2 HDGFL2 ZNF292 | 3.48e-07 | 497 | 84 | 10 | 36774506 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RPL10A MYH9 CELF1 EIF2S3 SMCHD1 KTN1 APAF1 SMC2 CEP128 HNRNPC | 3.55e-07 | 498 | 84 | 10 | 36634849 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UBR5 EIF2S3 APAF1 PSMC1 ACAA2 CPS1 MORC2 SMC2 TIMM44 DNAH5 HNRNPC | 1.05e-06 | 704 | 84 | 11 | 29955894 |
| Pubmed | 1.17e-06 | 222 | 84 | 7 | 37071664 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 1.47e-06 | 332 | 84 | 8 | 30595499 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.66e-06 | 148 | 84 | 6 | 32538781 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL10A MYH9 UTP11 EIF2S3 SMCHD1 UGGT1 ZNF638 PSMC1 MPHOSPH10 ZFC3H1 CACYBP SMC2 HNRNPC NOL8 | 1.81e-06 | 1257 | 84 | 14 | 36526897 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH9 VRK3 RASGRF2 UBR5 EIF2S3 UGGT1 PSMC1 SGO2 CLEC3B CACYBP SMC2 PKD1L3 HDGFL2 HNRNPC | 2.31e-06 | 1284 | 84 | 14 | 17353931 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL10A AARS1 MYH9 EIF2S3 SMCHD1 KTN1 ZNF638 NUMB CACYBP CAMSAP2 HDGFL2 NOL8 | 2.51e-06 | 934 | 84 | 12 | 33916271 |
| Pubmed | VRK3 EIF2S3 SYNE1 KTN1 ANKRD11 PSMC1 GON4L NUMB MPHOSPH10 ZFC3H1 MORC2 PNISR CAMSAP2 HDGFL2 NOL8 | 2.72e-06 | 1497 | 84 | 15 | 31527615 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.74e-06 | 361 | 84 | 8 | 26167880 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL10A AARS1 MYH9 ERLIN2 ANK3 EIF2S3 SYNE1 UGGT1 KTN1 CACYBP HNRNPC | 3.91e-06 | 807 | 84 | 11 | 30575818 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL10A NCOR2 AARS1 MYH9 UBR5 SMCHD1 KTN1 ZNF638 PSMC1 NFXL1 ACAA2 SMC2 TIMM44 HNRNPC | 4.23e-06 | 1353 | 84 | 14 | 29467282 |
| Pubmed | 4.25e-06 | 657 | 84 | 10 | 36180527 | ||
| Pubmed | RPL10A NCOR2 AARS1 MYH9 ATP8A1 CELF1 CENPE UBR5 ORC6 GCC2 KTN1 PSMC1 NFXL1 | 4.44e-06 | 1168 | 84 | 13 | 19946888 | |
| Pubmed | ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. | 5.76e-06 | 2 | 84 | 2 | 29453415 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33122718 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24417819 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 5.76e-06 | 2 | 84 | 2 | 16325480 | |
| Pubmed | RPL10A MYH9 ERLIN2 KTN1 ZNF638 MPHOSPH10 ZFC3H1 CPS1 SMC2 HNRNPC NOL8 | 6.17e-06 | 847 | 84 | 11 | 35850772 | |
| Pubmed | 7.08e-06 | 411 | 84 | 8 | 36652389 | ||
| Pubmed | 8.17e-06 | 708 | 84 | 10 | 39231216 | ||
| Pubmed | RPL10A NCOR2 MYH9 ERLIN2 VRK3 PIK3CA EIF2S3 KTN1 MPHOSPH10 CACYBP SMC2 CAMSAP2 HNRNPC | 8.95e-06 | 1247 | 84 | 13 | 27684187 | |
| Pubmed | 9.47e-06 | 116 | 84 | 5 | 30804394 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ERLIN2 CELF1 KTN1 NFXL1 MPHOSPH10 ZFC3H1 CACYBP MORC2 NOL8 ZNF292 | 9.92e-06 | 724 | 84 | 10 | 36232890 |
| Pubmed | 1.28e-05 | 19 | 84 | 3 | 18711365 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL10A ERLIN2 CENPE UTP11 SYNE1 ZNF644 KTN1 PSMC1 ACAA2 MPHOSPH10 CACYBP TIMM44 MTCH1 HNRNPC | 1.32e-05 | 1496 | 84 | 14 | 32877691 |
| Pubmed | 1.51e-05 | 601 | 84 | 9 | 33658012 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 29728365 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 20876525 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 24732756 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 30947633 | ||
| Pubmed | Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. | 1.73e-05 | 3 | 84 | 2 | 30217308 | |
| Pubmed | TDRD15 MYH9 ERLIN2 ANK3 UBR5 CCDC146 GCC2 EIF2S3 ZNF638 NOL8 | 1.82e-05 | 777 | 84 | 10 | 35844135 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL10A AARS1 MYH9 ANK3 UBR5 EIF2S3 UGGT1 PSMC1 CACYBP SMC2 HDGFL2 HNRNPC | 2.02e-05 | 1149 | 84 | 12 | 35446349 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.08e-05 | 626 | 84 | 9 | 33644029 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.34e-05 | 235 | 84 | 6 | 30258100 | |
| Pubmed | 2.41e-05 | 638 | 84 | 9 | 31182584 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPL10A MYH9 CELF1 UTP11 SYNE1 ZNF638 MPHOSPH10 PNISR HNRNPC NOL8 | 2.51e-05 | 807 | 84 | 10 | 22681889 |
| Pubmed | RPL10A AARS1 MYH9 EIF2S3 SMCHD1 KTN1 MAP7D2 CACYBP SMC2 HNRNPC | 2.57e-05 | 809 | 84 | 10 | 32129710 | |
| Pubmed | 2.72e-05 | 71 | 84 | 4 | 33541421 | ||
| Pubmed | 2.85e-05 | 652 | 84 | 9 | 31180492 | ||
| Pubmed | 3.01e-05 | 25 | 84 | 3 | 36708875 | ||
| Pubmed | Shugoshin-2 is essential for the completion of meiosis but not for mitotic cell division in mice. | 3.45e-05 | 4 | 84 | 2 | 18765791 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23207240 | ||
| Pubmed | Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. | 3.45e-05 | 4 | 84 | 2 | 31836389 | |
| Pubmed | RPL10A MYH9 ERLIN2 ATP8A1 ANK3 EIF2S3 SYNE1 KTN1 PSMC1 MAP7D2 EIF2S3B CAMSAP2 HNRNPC | 3.78e-05 | 1431 | 84 | 13 | 37142655 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.17e-05 | 857 | 84 | 10 | 25609649 | |
| Pubmed | 5.57e-05 | 711 | 84 | 9 | 33022573 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 35114328 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 35414777 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 36448053 | ||
| Pubmed | 5.96e-05 | 407 | 84 | 7 | 12693553 | ||
| Pubmed | 6.05e-05 | 408 | 84 | 7 | 33766124 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 6.34e-05 | 411 | 84 | 7 | 35182466 | |
| Pubmed | 6.47e-05 | 725 | 84 | 9 | 27025967 | ||
| Pubmed | 7.15e-05 | 419 | 84 | 7 | 15635413 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL10A MYH9 VRK3 CELF1 EIF2S3 SMCHD1 PSMC1 MPHOSPH10 CACYBP SMC2 TIMM44 HNRNPC | 7.59e-05 | 1318 | 84 | 12 | 30463901 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | RPL10A SMCHD1 KTN1 ANKRD11 ZNF638 PSMC1 ACAA2 MPHOSPH10 PNISR HNRNPC | 7.66e-05 | 922 | 84 | 10 | 27609421 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 8.37e-05 | 582 | 84 | 8 | 20467437 | |
| Pubmed | UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis. | 8.59e-05 | 6 | 84 | 2 | 37087976 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 35296779 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 21738484 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 8.72e-05 | 754 | 84 | 9 | 33060197 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL10A MYH9 UTP11 EIF2S3 SYNE1 NUMB EIF2S3B MPHOSPH10 CPS1 HNRNPC | 9.72e-05 | 949 | 84 | 10 | 36574265 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.13e-04 | 608 | 84 | 8 | 36089195 | |
| Pubmed | RPL10A UBR5 UTP11 EIF2S3 SMCHD1 PSMC1 CACYBP SMC2 TIMM44 HNRNPC | 1.17e-04 | 971 | 84 | 10 | 33306668 | |
| Pubmed | Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. | 1.20e-04 | 7 | 84 | 2 | 19723899 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 15669143 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RPL10A AARS1 ERLIN2 UBR5 SMCHD1 UGGT1 PSMC1 EIF2S3B CACYBP SMC2 | 1.20e-04 | 974 | 84 | 10 | 28675297 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.22e-04 | 317 | 84 | 6 | 17620599 | |
| Pubmed | 1.34e-04 | 202 | 84 | 5 | 24639526 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL10A NCOR2 MYH9 UTP11 EIF2S3 SMCHD1 ZNF638 MPHOSPH10 HNRNPC NOL8 | 1.36e-04 | 989 | 84 | 10 | 36424410 |
| Pubmed | 1.40e-04 | 803 | 84 | 9 | 36517590 | ||
| Pubmed | 1.45e-04 | 109 | 84 | 4 | 29511296 | ||
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | 1.57e-04 | 332 | 84 | 6 | 29053956 | |
| Pubmed | RPL10A ERLIN2 CELF1 STXBP5 UGGT1 KTN1 NFXL1 MAP7D2 NUMB CACYBP | 1.57e-04 | 1007 | 84 | 10 | 34597346 | |
| Pubmed | Sequential assembly of centromeric proteins in male mouse meiosis. | 1.60e-04 | 8 | 84 | 2 | 19283064 | |
| Pubmed | Regulation of membrane traffic by phosphoinositide 3-kinases. | 1.60e-04 | 8 | 84 | 2 | 16467569 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 17903303 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 11279518 | ||
| Pubmed | 1.60e-04 | 210 | 84 | 5 | 16565220 | ||
| Pubmed | NCOR2 AARS1 MYH9 UBR5 SMCHD1 SMARCAL1 CACYBP MORC2 SMC2 HDGFL2 | 1.67e-04 | 1014 | 84 | 10 | 32416067 | |
| Pubmed | 1.72e-04 | 483 | 84 | 7 | 36912080 | ||
| Pubmed | 1.84e-04 | 653 | 84 | 8 | 22586326 | ||
| Pubmed | 1.87e-04 | 217 | 84 | 5 | 34048709 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.91e-04 | 344 | 84 | 6 | 30333137 | |
| Pubmed | 1.95e-04 | 493 | 84 | 7 | 15368895 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 2.00e-04 | 495 | 84 | 7 | 27705803 | |
| Interaction | DHX40 interactions | CELF1 UBR5 ZNF644 KTN1 ANKRD11 ZNF638 MPHOSPH10 ZFC3H1 PNISR HNRNPC NOL8 | 6.89e-09 | 249 | 84 | 11 | int:DHX40 |
| Interaction | SMC5 interactions | RPL10A NCOR2 MYH9 BAZ2B UTP11 EIF2S3 SMCHD1 ZNF644 KTN1 ANKRD11 ZNF638 SGO2 EIF2S3B MPHOSPH10 HDGFL2 HNRNPC NOL8 | 6.44e-07 | 1000 | 84 | 17 | int:SMC5 |
| Interaction | CEBPA interactions | NCOR2 AARS1 MYH9 RESF1 CELF1 UBR5 BAZ2B ORC6 EIF2S3 SMCHD1 ZNF644 PSMC1 CACYBP MORC2 SMC2 HDGFL2 HNRNPC ZNF292 NAA16 | 6.51e-07 | 1245 | 84 | 19 | int:CEBPA |
| Interaction | CEBPB interactions | RPL10A NCOR2 AARS1 MYH9 VRK3 CELF1 EIF2S3 SMCHD1 ZNF644 KTN1 ZNF638 PSMC1 ACAA2 MPHOSPH10 CACYBP SMC2 TIMM44 HDGFL2 HNRNPC ZNF292 | 1.41e-06 | 1443 | 84 | 20 | int:CEBPB |
| Interaction | DNAJC17 interactions | 1.45e-06 | 134 | 84 | 7 | int:DNAJC17 | |
| Interaction | NUP43 interactions | NCOR2 ATP8A1 RESF1 UBR5 BAZ2B ZNF644 ANKRD11 GON4L MPHOSPH10 ZFC3H1 MORC2 ZNF518A ZNF292 | 1.80e-06 | 625 | 84 | 13 | int:NUP43 |
| Interaction | H3C1 interactions | RPL10A MYH9 ANK3 GCC2 SYNE1 SMCHD1 ZNF644 ZNF638 LAMA2 PWWP3B MORC2 TIMM44 HDGFL2 ESCO1 ZNF292 | 4.19e-06 | 901 | 84 | 15 | int:H3C1 |
| Interaction | BIRC3 interactions | RPL10A NCOR2 AARS1 MYH9 ERLIN2 EIF2S3 SYNE1 SMCHD1 UGGT1 KTN1 CD40LG PSMC1 SGO2 CACYBP SMC2 TIMM44 DNAH5 HNRNPC | 7.66e-06 | 1334 | 84 | 18 | int:BIRC3 |
| Interaction | SNRNP40 interactions | NCOR2 UBR5 BAZ2B ZNF644 SMARCAL1 GON4L MPHOSPH10 ZFC3H1 PNISR HDGFL2 HNRNPC NOL8 | 1.27e-05 | 637 | 84 | 12 | int:SNRNP40 |
| Interaction | FBXO22 interactions | NCOR2 AARS1 ERLIN2 ANK3 RASGRF2 CENPE KTN1 ANKRD11 MORC2 HDGFL2 ZNF292 | 1.46e-05 | 540 | 84 | 11 | int:FBXO22 |
| Interaction | POLR1G interactions | BAZ2B SMCHD1 ZNF644 ANKRD11 SGO2 MPHOSPH10 ZFC3H1 MORC2 NOL8 ZNF292 | 3.57e-05 | 489 | 84 | 10 | int:POLR1G |
| Interaction | MYCN interactions | RPL10A MYH9 UTP11 EIF2S3 SYNE1 SMCHD1 UGGT1 KTN1 ZNF638 PSMC1 NUMB MPHOSPH10 ZFC3H1 CACYBP SMC2 HDGFL2 HNRNPC | 4.31e-05 | 1373 | 84 | 17 | int:MYCN |
| Interaction | MAPT interactions | RPL10A TTC7A AARS1 ERLIN2 ANK3 PIK3CA EIF2S3 KTN1 PSMC1 NUMB ACAA2 CACYBP CEP128 HNRNPC ARMC1 | 5.36e-05 | 1119 | 84 | 15 | int:MAPT |
| Interaction | H2BC12 interactions | 5.92e-05 | 322 | 84 | 8 | int:H2BC12 | |
| Interaction | APEX1 interactions | MYH9 SMCHD1 ZNF644 SMARCAL1 KTN1 APAF1 ANKRD11 ZNF638 NUMB MORC2 SPOCD1 HDGFL2 FCHO1 HNRNPC NOL8 ZNF292 | 6.18e-05 | 1271 | 84 | 16 | int:APEX1 |
| Interaction | CAMSAP2 interactions | 7.53e-05 | 169 | 84 | 6 | int:CAMSAP2 | |
| Interaction | CASP4 interactions | 7.58e-05 | 54 | 84 | 4 | int:CASP4 | |
| Interaction | TFE3 interactions | 9.38e-05 | 344 | 84 | 8 | int:TFE3 | |
| Interaction | H2BC4 interactions | 1.04e-04 | 259 | 84 | 7 | int:H2BC4 | |
| Interaction | POLR1E interactions | 1.06e-04 | 350 | 84 | 8 | int:POLR1E | |
| Interaction | SLX4 interactions | RESF1 UBR5 BAZ2B EIF2S3 SMCHD1 ZNF644 ZFC3H1 MORC2 ZNF518A NOL8 | 1.31e-04 | 572 | 84 | 10 | int:SLX4 |
| Interaction | ZNF280D interactions | 1.33e-04 | 24 | 84 | 3 | int:ZNF280D | |
| Interaction | H2BC21 interactions | VRK3 SMCHD1 ZNF644 SMARCAL1 ZNF638 SGO2 SMC2 DNAH5 ESCO1 ZNF292 NAA16 | 1.45e-04 | 696 | 84 | 11 | int:H2BC21 |
| Interaction | DDX23 interactions | 1.73e-04 | 480 | 84 | 9 | int:DDX23 | |
| Interaction | CENPA interactions | 1.76e-04 | 377 | 84 | 8 | int:CENPA | |
| Interaction | HECTD1 interactions | RPL10A CENPE EIF2S3 SMCHD1 KTN1 ANKRD11 SGO2 ATG14 MPHOSPH10 ZFC3H1 SMC2 MTCH1 NOL8 | 2.07e-04 | 984 | 84 | 13 | int:HECTD1 |
| Interaction | CDC5L interactions | MYH9 UBR5 ORC6 SYNE1 SMCHD1 SMARCAL1 ZNF638 PSMC1 SMC2 PNISR HNRNPC NOL8 | 2.14e-04 | 855 | 84 | 12 | int:CDC5L |
| Interaction | RNF2 interactions | RPL10A ANK3 UBR5 EIF2S3 SYNE1 SMCHD1 ZNF638 NFXL1 SGO2 ATG14 MPHOSPH10 HNRNPC | 2.41e-04 | 866 | 84 | 12 | int:RNF2 |
| Interaction | KCNA3 interactions | RPL10A MYH9 ANK3 EIF2S3 KTN1 PSMC1 NUMB CACYBP MORC2 SMC2 TIMM44 DNAH5 | 2.54e-04 | 871 | 84 | 12 | int:KCNA3 |
| Interaction | EGLN3 interactions | NCOR2 UBR5 ZNF644 UGGT1 ANKRD11 PSMC1 NFXL1 MAP7D2 NUMB SGO2 CACYBP SMC2 TIMM44 CAMSAP2 MTCH1 | 2.72e-04 | 1296 | 84 | 15 | int:EGLN3 |
| Interaction | EFTUD2 interactions | RPL10A MYH9 UBR5 EIF2S3 SMCHD1 UGGT1 KTN1 ZNF638 PSMC1 CACYBP CPS1 SMC2 TIMM44 ANKRD55 HDGFL2 HNRNPC | 2.82e-04 | 1449 | 84 | 16 | int:EFTUD2 |
| Interaction | SRF interactions | 2.90e-04 | 139 | 84 | 5 | int:SRF | |
| Interaction | MEN1 interactions | RPL10A MYH9 UBR5 SMCHD1 ZNF644 SMARCAL1 KTN1 ZNF638 MPHOSPH10 ZFC3H1 SMC2 HNRNPC NOL8 | 3.19e-04 | 1029 | 84 | 13 | int:MEN1 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RESF1 CENPE BAZ2B PIK3CA GCC2 SMCHD1 ZNF644 KTN1 ZNF638 MPHOSPH10 SMC2 PNISR ARMC1 | 1.65e-07 | 656 | 84 | 13 | M18979 |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP | 3.74e-06 | 200 | 84 | 7 | M3860 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RPL10A MYH9 ATP8A1 RESF1 CELF1 UBR5 SYNE1 SMCHD1 ZNF644 KTN1 ANKRD11 ZNF638 ZFC3H1 CACYBP PNISR ZNF292 | 1.81e-05 | 1492 | 84 | 16 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.86e-05 | 466 | 84 | 9 | M13522 | |
| Coexpression | TBK1.DF_DN | 3.78e-05 | 286 | 84 | 7 | M2864 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN | 4.17e-05 | 197 | 84 | 6 | M10015 | |
| Coexpression | GSE15659_RESTING_VS_ACTIVATED_TREG_DN | 4.29e-05 | 198 | 84 | 6 | M3563 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN | 4.29e-05 | 198 | 84 | 6 | M10020 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 4.41e-05 | 199 | 84 | 6 | M7607 | |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_UP | 5.39e-05 | 64 | 84 | 4 | M1405 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | AARS1 RESF1 CELF1 BAZ2B PIK3CA ORC6 CDKL3 GON4L NUMB ATG14 PNISR | 6.23e-05 | 822 | 84 | 11 | M6782 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOR2 CENPE UBR5 BAZ2B GCC2 SMCHD1 ZNF638 NUMB PNISR CAMSAP2 ZNF292 | 8.94e-05 | 856 | 84 | 11 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPE UBR5 KTN1 ANKRD11 ZNF638 MAP7D2 SGO2 MPHOSPH10 SMC2 ESCO1 ZNF518A NOL8 | 1.04e-06 | 532 | 83 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPE ANKRD11 ZNF638 SGO2 MPHOSPH10 SMC2 PNISR ZNF518A NOL8 ZNF292 NAA16 | 2.09e-06 | 469 | 83 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | RESF1 ANK3 CENPE ORC6 GCC2 SMCHD1 ZNF644 CDKL3 SGO2 PWWP3B MPHOSPH10 CACYBP SMC2 ZNF518A NOL8 ZNF292 NAA16 | 5.03e-06 | 1241 | 83 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.58e-05 | 375 | 83 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | RESF1 VRK3 CENPE ORC6 GCC2 ZNF644 ZNF638 SGO2 PWWP3B MPHOSPH10 CACYBP SMC2 CEP128 ZNF518A ZNF292 NAA16 | 2.36e-05 | 1252 | 83 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CENPE ORC6 GCC2 SMCHD1 ZNF644 KTN1 SGO2 PWWP3B MPHOSPH10 CACYBP SMC2 PNISR CEP128 NOL8 ZNF292 NAA16 | 2.48e-05 | 1257 | 83 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ATP8A1 CENPE UBR5 GCC2 EIF2S3 KTN1 MAP7D2 TRIM71 MPHOSPH10 CACYBP PNISR ZNF518A NOL8 ZNF292 | 2.71e-05 | 989 | 83 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 2.78e-05 | 403 | 83 | 9 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | RESF1 ANK3 CENPE ORC6 GCC2 SMCHD1 ZNF644 CDKL3 SGO2 PWWP3B MPHOSPH10 CACYBP SMC2 ZNF518A NOL8 ZNF292 NAA16 | 4.42e-05 | 1468 | 83 | 17 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.41e-05 | 339 | 83 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATP8A1 CENPE UBR5 STXBP5 KTN1 GON4L MAP7D2 MPHOSPH10 PNISR ZNF518A NOL8 ZNF292 | 8.98e-05 | 831 | 83 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.99e-05 | 186 | 83 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.07e-04 | 192 | 83 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CENPE ORC6 GCC2 SMCHD1 ZNF644 KTN1 SGO2 PWWP3B MPHOSPH10 CACYBP SMC2 PNISR CEP128 NOL8 ZNF292 NAA16 | 1.46e-04 | 1459 | 83 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | MYH9 ATP8A1 ANK3 RASGRF2 PIK3CA ZNF644 APAF1 SMC2 PNISR CAMSAP2 ZNF292 | 2.08e-04 | 774 | 83 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | KATNBL1 ATP8A1 RESF1 CENPE ANKRD11 ZNF638 TRIM71 SMC2 PNISR ESCO1 NOL8 | 2.94e-04 | 806 | 83 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 3.07e-04 | 150 | 83 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.26e-04 | 152 | 83 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | RESF1 ANK3 GCC2 EIF2S3 SMCHD1 ANKRD11 ZNF638 ZFC3H1 PNISR ANKRD55 NAA16 | 1.08e-13 | 195 | 84 | 11 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.84e-09 | 197 | 84 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.16e-09 | 199 | 84 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-08 | 173 | 84 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-08 | 173 | 84 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-08 | 173 | 84 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.72e-08 | 178 | 84 | 7 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue | 6.38e-08 | 186 | 84 | 7 | 5108d9b7a081876ca34594b110d58df56063f542 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.65e-08 | 191 | 84 | 7 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.65e-08 | 191 | 84 | 7 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.12e-08 | 196 | 84 | 7 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.12e-08 | 196 | 84 | 7 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.01e-07 | 199 | 84 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-07 | 200 | 84 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.05e-07 | 200 | 84 | 7 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 175 | 84 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-06 | 177 | 84 | 6 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.52e-06 | 188 | 84 | 6 | f7dd01084ad14d2a2d8adf552e811b84eebf5514 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.67e-06 | 191 | 84 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-06 | 192 | 84 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-06 | 193 | 84 | 6 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 1.77e-06 | 193 | 84 | 6 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-06 | 193 | 84 | 6 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-06 | 193 | 84 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-06 | 193 | 84 | 6 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-06 | 193 | 84 | 6 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | severe-CD4+_Tcm|severe / disease stage, cell group and cell class | 1.83e-06 | 194 | 84 | 6 | 380fbd19b72af6767f98bbf50329686b76d59c54 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-06 | 195 | 84 | 6 | 07035a5972a78b98e4ab2167e3a5000f9f3b0826 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-06 | 195 | 84 | 6 | 5001e68df2ad5df9dc93ae235f984ffafea6b521 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-06 | 196 | 84 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.00e-06 | 197 | 84 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.12e-06 | 199 | 84 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.12e-06 | 199 | 84 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.12e-06 | 199 | 84 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.12e-06 | 199 | 84 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.16e-05 | 156 | 84 | 5 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 157 | 84 | 5 | d85a2f56ae313baa9738e81d2756ce1fe1ba50db | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.81e-05 | 171 | 84 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-05 | 171 | 84 | 5 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 173 | 84 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 175 | 84 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 176 | 84 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 177 | 84 | 5 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 178 | 84 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-05 | 181 | 84 | 5 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 183 | 84 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 183 | 84 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.57e-05 | 184 | 84 | 5 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.57e-05 | 184 | 84 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.57e-05 | 184 | 84 | 5 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 186 | 84 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 186 | 84 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 187 | 84 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.85e-05 | 188 | 84 | 5 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 2.85e-05 | 188 | 84 | 5 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 258ef4a52f90236dbed92f325ca033c8fa6156a5 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.08e-05 | 191 | 84 | 5 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-05 | 191 | 84 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.08e-05 | 191 | 84 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-05 | 191 | 84 | 5 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.08e-05 | 191 | 84 | 5 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-05 | 191 | 84 | 5 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-05 | 192 | 84 | 5 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.16e-05 | 192 | 84 | 5 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 3.16e-05 | 192 | 84 | 5 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 3.16e-05 | 192 | 84 | 5 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.16e-05 | 192 | 84 | 5 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | remission-CD4+_T_naive|World / disease stage, cell group and cell class | 3.16e-05 | 192 | 84 | 5 | 4bd94ce876d70f93dbdfad1dcd09e1468213cf57 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 3.23e-05 | 193 | 84 | 5 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 3.23e-05 | 193 | 84 | 5 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | mild_COVID-19-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 3.23e-05 | 193 | 84 | 5 | 42ddacc55658ea6ba4248ac19c9c3709f342b4f5 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 84 | 5 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.32e-05 | 194 | 84 | 5 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.32e-05 | 194 | 84 | 5 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.32e-05 | 194 | 84 | 5 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | Healthy_donor-CD4+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 3.32e-05 | 194 | 84 | 5 | a8a0368a4e0eb5654fdffc8a779b08ad402aa2eb | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.32e-05 | 194 | 84 | 5 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.32e-05 | 194 | 84 | 5 | 31a98ce929ee6cf6a9747e384f9a06336af49fd5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.32e-05 | 194 | 84 | 5 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.32e-05 | 194 | 84 | 5 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-05 | 194 | 84 | 5 | 89e30624e389ff7b4a3b6e02d2b77cdeae263ded | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Mild / Disease group, lineage and cell class | 3.40e-05 | 195 | 84 | 5 | 8aec807b24bcebf1a8011d676d2143b6fc570f1d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 3.40e-05 | 195 | 84 | 5 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-05 | 195 | 84 | 5 | d9965223430aba1ec0b1b77b5bd40d3a01e42e95 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.40e-05 | 195 | 84 | 5 | d056c806c7ad38ca425bdaa44385424a7f43f915 | |
| ToppCell | COVID-19_Moderate-CD4+_T_naive|World / disease group, cell group and cell class | 3.40e-05 | 195 | 84 | 5 | 38d65cf0895f7a99d789ec3dcbd56a7506706d38 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 195 | 84 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-05 | 195 | 84 | 5 | eca24039bde02f4677f1f89a373f501c649ec2a5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-05 | 195 | 84 | 5 | 1d3c51a3be5ad1fbc465c5f684565ec4c6f35f54 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 195 | 84 | 5 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.40e-05 | 195 | 84 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-05 | 195 | 84 | 5 | 8ae2886dd4cfc70c58b61fbb6994f0a22f8c9127 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.40e-05 | 195 | 84 | 5 | 6421d949bfebcd985bea7efc5731a1ca79350b61 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 196 | 84 | 5 | 85684b881655e47f06f0cf00721183825fa00913 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-05 | 196 | 84 | 5 | ffc2728663a72ec62fa2e5b1054368fb56d18c62 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 196 | 84 | 5 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.50e-09 | 49 | 55 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Clorgyline | 1.83e-07 | 168 | 83 | 8 | ctd:D003010 | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A | 8.30e-06 | 199 | 83 | 7 | 2001_UP | |
| Disease | osteoarthritis, knee, body mass index | 5.19e-06 | 41 | 82 | 4 | EFO_0004340, EFO_0004616 | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 7.63e-06 | 2 | 82 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 5.14e-05 | 26 | 82 | 3 | DOID:234 (is_implicated_in) | |
| Disease | Testicular Germ Cell Tumor | 5.21e-05 | 73 | 82 | 4 | EFO_1000566 | |
| Disease | hypopituitarism (implicated_via_orthology) | 1.14e-04 | 6 | 82 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH9 RASGRF2 PIK3CA SYNE1 ZNF644 SMARCAL1 KTN1 LAMA2 MAP7D2 SPOCD1 FSCB | 1.86e-04 | 1074 | 82 | 11 | C0006142 |
| Disease | Cholestasis of pregnancy | 2.11e-04 | 8 | 82 | 2 | C0268318 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.70e-04 | 45 | 82 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | leukodystrophy (implicated_via_orthology) | 2.71e-04 | 9 | 82 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 2.71e-04 | 9 | 82 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | X-21467 measurement | 2.71e-04 | 9 | 82 | 2 | EFO_0020007 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 5.16e-04 | 56 | 82 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Fetal Alcohol Spectrum Disorders | 5.83e-04 | 13 | 82 | 2 | C2985290 | |
| Disease | X-24588 measurement | 5.83e-04 | 13 | 82 | 2 | EFO_0800898 | |
| Disease | lean body mass | 6.65e-04 | 379 | 82 | 6 | EFO_0004995 | |
| Disease | Colorectal Carcinoma | 7.48e-04 | 702 | 82 | 8 | C0009402 | |
| Disease | myopia (is_implicated_in) | 8.93e-04 | 16 | 82 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 1.01e-03 | 17 | 82 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.01e-03 | 17 | 82 | 2 | C0496905 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.01e-03 | 17 | 82 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Carcinoma in situ of stomach | 1.01e-03 | 17 | 82 | 2 | C0154060 | |
| Disease | Fetal Alcohol Syndrome | 1.01e-03 | 17 | 82 | 2 | C0015923 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.03e-03 | 71 | 82 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Colorectal Neoplasms | 1.06e-03 | 277 | 82 | 5 | C0009404 | |
| Disease | Chronic myeloproliferative disorder | 1.27e-03 | 19 | 82 | 2 | C1292778 | |
| Disease | fatty acid measurement | 1.37e-03 | 436 | 82 | 6 | EFO_0005110 | |
| Disease | Stomach Carcinoma | 1.55e-03 | 21 | 82 | 2 | C0699791 | |
| Disease | Seckel syndrome | 1.70e-03 | 22 | 82 | 2 | C0265202 | |
| Disease | Nasopharyngeal carcinoma | 1.70e-03 | 22 | 82 | 2 | C2931822 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.80e-03 | 312 | 82 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.87e-03 | 315 | 82 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.87e-03 | 315 | 82 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 2.03e-03 | 321 | 82 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | apolipoprotein L1 measurement | 2.20e-03 | 25 | 82 | 2 | EFO_0021854 | |
| Disease | pain | 2.20e-03 | 196 | 82 | 4 | EFO_0003843 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.29e-03 | 330 | 82 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | Alzheimer disease | 2.34e-03 | 485 | 82 | 6 | MONDO_0004975 | |
| Disease | ergothioneine measurement | 2.37e-03 | 26 | 82 | 2 | EFO_0021163 | |
| Disease | osteoarthritis (is_implicated_in) | 2.75e-03 | 28 | 82 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.75e-03 | 28 | 82 | 2 | DOID:4194 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEAMKNKQKSVTAKD | 111 | Q9H6B1 | |
| KTDAVAEMKAVSKNK | 51 | Q6PI77 | |
| TKKVCKNSAVMLKQE | 911 | O14727 | |
| KKQSKIQSQMKVEKA | 596 | Q6ZU80 | |
| MVEKQTGKKDKDKVS | 21 | Q6UB99 | |
| NKEETKKENSFEMQK | 101 | P29965 | |
| KSKQEEFQKEVLKAM | 86 | Q6ZNE5 | |
| MVVKFADTQKDKEQK | 181 | Q92879 | |
| KQQAIMAAEEKRKQK | 921 | Q9UIF8 | |
| IQSKDTKGMEVKQIK | 531 | Q8IVW4 | |
| ASTKVMKAQQVVKSE | 201 | Q9NVT9 | |
| VAMVEFKKKTSDNSK | 401 | Q3KP44 | |
| KSEVVEMVKKQVKVV | 781 | Q9Y2Q0 | |
| NKKVMRTKSSEKAAN | 106 | Q8N436 | |
| TSQKEMDKAETKTKK | 156 | O14526 | |
| KLTESNSAMVKSKKQ | 2271 | Q9Y618 | |
| NSAMVKSKKQEINKK | 2276 | Q9Y618 | |
| RKKISNFTNKNMKEV | 26 | Q9H079 | |
| KIEKEQSKQAVEMKN | 216 | P07910 | |
| EQVEMKAKVVQSEVK | 351 | Q2Q1W2 | |
| KNQQKEMIETKVVKE | 271 | Q9Y5Y7 | |
| MSQKKFEEIKKANQA | 81 | Q6ZNB6 | |
| KAMIEKQKEAAETKA | 501 | Q96T17 | |
| MVGKSQQTDVIEKKK | 1 | Q5H9T9 | |
| KKRTMFQKIVDQSKT | 676 | P16499 | |
| KVLSQEMQKIFVKKD | 731 | Q6N069 | |
| AEKSKIETEIKNKMQ | 31 | Q9HB71 | |
| VKSSFEKRQEKMNEK | 356 | O00566 | |
| TEKMLQDKVNKTSKE | 1046 | Q86UP2 | |
| SQEFQKKLVDTMEKK | 376 | Q8N8V2 | |
| VNQKNMTALEKKKEA | 1806 | P24043 | |
| STKSKTIQVKNMKNK | 481 | Q92887 | |
| KATDKSFVEKVMQEQ | 536 | P35579 | |
| TDEIIAMKKNVAKVK | 381 | Q76FK4 | |
| AMKKNVAKVKNSTEF | 386 | Q76FK4 | |
| VAKVKNSTEFSQMEK | 391 | Q76FK4 | |
| EAVQKVNKAGMEKEK | 556 | Q7Z4V5 | |
| QEKKDETQKVQMKFL | 721 | P42336 | |
| QKVMEKETEKKISEI | 231 | O94905 | |
| NVTMDEIKKAVKEAN | 496 | P21439 | |
| RKDMKTQEEKQKQLT | 551 | Q9Y6X9 | |
| SQAVKAMKEENVKTV | 446 | P31327 | |
| KKENIKMKQEVEDSV | 96 | Q8IWJ2 | |
| MKKSSAKQLQEVEKV | 656 | Q3T8J9 | |
| SIKEKVKAFQMKASS | 2211 | Q12955 | |
| ASKMKQVSQSEKTKA | 3886 | Q12955 | |
| TMKAKTEVQVAEKNK | 131 | Q7Z692 | |
| FKATVKDDMQKAKTA | 31 | Q8TC29 | |
| VKKESSQMESVKEEK | 321 | Q5FWF5 | |
| KAAKVQKLSKNEVLM | 391 | Q2VIR3 | |
| QIRNKVKDMKTKETS | 576 | Q9Y267 | |
| EAQKKKMEAAFTKQR | 776 | Q08AD1 | |
| ENTKEIVAKMKESQE | 1611 | Q02224 | |
| KKDVNETQKKVSEME | 1836 | Q02224 | |
| ETQKKVSEMEQLKKQ | 1841 | Q02224 | |
| TMKAQAAEKVKAEVQ | 3246 | Q8TE73 | |
| KQMQDAKKAETDKIV | 211 | P49757 | |
| VSNKDDMKTSLKKVV | 181 | Q9NZJ7 | |
| MDKTQKVKVKKETVN | 226 | Q9Y3A2 | |
| DVKKQQQMAALTKEK | 1616 | A6NHR9 | |
| MVSQVKDFVKKLQSK | 4171 | Q8NF91 | |
| MLNSESKNKVNIKKV | 681 | B5MCY1 | |
| KENKNKIDISAVMSV | 206 | Q5H9M0 | |
| SKQTKALMDKLQKTV | 1116 | O14827 | |
| KEKMVSNTKSVDTKA | 1421 | Q9HCM1 | |
| AKEMTTKDKTKQQQK | 681 | Q9NZC9 | |
| KDQADMQKVKVTVLA | 721 | Q7Z443 | |
| ECQVKKVNKMTSKSK | 1066 | Q562F6 | |
| VDKNKMVATSGVKKA | 156 | Q9Y5N6 | |
| RMKVTNEDFKKSKEN | 411 | P62191 | |
| EQKMNNFIEKVKTKS | 726 | Q5T5C0 | |
| MTQIKIDEKEQKSKD | 461 | Q8IYE0 | |
| IVSKLQEMKEKKEAQ | 591 | Q8IYE0 | |
| IEVKTKKGKQTMQVD | 206 | P42765 | |
| KKCLSVMEAKVKAQT | 771 | P49588 | |
| IVNAKKDVVNTKMFE | 31 | P05452 | |
| GKVQKMVSFNSKVEK | 1031 | Q6ZMY3 | |
| KKQLAMTEENKKESQ | 2006 | O60281 | |
| NTEDIMKQKQKFVDK | 396 | Q8IV63 | |
| QVLKKMNKTQTKSED | 346 | Q6AHZ1 | |
| AKVDEVKSTIKFQMK | 146 | P62906 | |
| DASSKKMKEKQQEVE | 806 | O95347 | |
| VMAAEVAKNKESVNK | 856 | O95347 | |
| IAQRKTQKKTFMKDS | 561 | Q9H582 | |
| NVKQELAKNKEMKES | 66 | O43615 | |
| VETKATQNFKVMAAK | 271 | Q9ULT0 | |
| KKQEKMTKFQEAVTF | 11 | Q86WZ6 | |
| MEQQRSQLSKKEKKA | 256 | Q8TF01 | |
| QQVMKESKEKLTKTK | 391 | O60293 | |
| MVTKQVTDAESKLKK | 821 | O60293 | |
| TEKFMAKQRKEKEQN | 1956 | Q14966 | |
| KVKVQKKADMVNEDL | 1206 | Q9NYU2 | |
| KKKAAVIIMAVEKQT | 861 | O95071 | |
| KAAKVQKLSKNEVLM | 391 | P41091 |